Barclays »

Fennec Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2023-12-31 $282k 25k 11.25
2023-09-30 $26k 3.5k 7.51
2023-06-30 $32k 3.6k 8.80
2023-03-31 $81k 9.7k 8.31
2022-12-31 $89k 9.3k 9.61
2021-09-30 $25k 2.6k 9.44
2021-06-30 $21k 3.0k 7.10
2021-03-31 $113k 18k 6.21
2020-12-31 $53k 7.0k 7.55
2020-09-30 $60k 9.8k 6.12
2020-06-30 $100k 12k 8.34
2019-06-30 $2.0k 543 3.68
2019-03-31 $17k 3.4k 4.98
2018-09-30 $38k 4.6k 8.21
2018-06-30 $8.0k 830 9.64